![](/img/cover-not-exists.png)
Bcl-2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women
Delgado-Vega, A M, Castiblanco, J, Gomez, L M, Diaz-Gallo, L-M, Rojas-Villarraga, A, Anaya, J-MVolume:
69
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/ard.2008.100818
Date:
February, 2010
File:
PDF, 231 KB
english, 2010